Development of a simple binary response questionnaire to identify airflow obstruction in a smoking population in Argentina

European Respiratory Review

Volumn 24, Issue 136, 2015, Pages 320-326

  Bergna, Miguel A ^a   García, Gabriel R ^a   Alchapar, Ramon ^a   Altieri, Hector ^a   Figueroa Casas, Juan C ^a   Larrateguy, Luis ^a   Nannini, Luis J ^a   Pascansky, Daniel ^a   Grabre, Pedro ^a   Zabert, Gustavo ^a   Miravitlles, Marc ^b  

^a Argentine Respiratory Medicine Association ^*  (Argentina)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AIRWAY OBSTRUCTION; ARGENTINA; CHRONIC COUGH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COPD DETECTION QUESTIONNAIRE; DIAGNOSTIC VALUE; DYSPNEA; FEMALE; HEALTH SURVEY; HUMAN; INSTRUMENT VALIDATION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; PUBLIC HOSPITAL; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE ASSESSMENT; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING HABIT; WHEEZING; ADVERSE EFFECTS; AREA UNDER THE CURVE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; EPIDEMIOLOGY; LUNG; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SMOKING; SPIROMETRY; STATISTICAL MODEL;

ADULT; AIRWAY OBSTRUCTION; AREA UNDER CURVE; ARGENTINA; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH SURVEYS; HOSPITALS, PUBLIC; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SMOKING; SPIROMETRY; SURVEYS AND QUESTIONNAIRES;

EID: 84930468634     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.00005214     Document Type: Review

References (25)

1. 1 Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613–620.
2. 2 van Schayck CP, van der Heijden FMMA, van den Boom G, et al. Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project. Thorax 2000; 55: 562–565.
3. 3 Calverley PM, Nordyke RJ, Halbert RJ, et al. Development of a population-based screening questionnaire for COPD. COPD 2005; 2: 225–232.
4. 4 Price DB, Tinkelman DG, Nordyke RJ, et al. Scoring system and clinical application of COPD diagnosis questionnaires. Chest 2006; 129: 1531–1539.
5. 5 Kida K, Wakabayashi R, Mizuuchi T, et al. Screening for suspected chronic obstructive pulmonary disease with an eleven-item pre-interview questionnaire (11-Q). Intern Med 2006; 45: 1201–1207.
6. 6 Miravitlles M, Llor C, Calvo E, et al. Validacion de la version traducida del Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Su utilidad y la del FEV1/FEV6 para el diagnostico de enfermedad pulmonar obstructiva cronica [Validation of the Spanish version of the Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Its usefulness and that of FEV1/FEV6 for the diagnosis of COPD]. Med Clin (Barc) 2012; 139: 522–530.
7. 7 Broekhuizen BD, Sachs AP, Oostvogels R, et al. The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review. Fam Pract 2009; 26: 260–268.
8. 8 Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.
9. 9 Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. GOLD, 2010. Available from: www.goldcopd.org
10. 10 Hosmer DW, Lemeshow S. Goodness-of-fit tests for the multiple logistic regression model. Commun Stat 1980; 9: 1043–1069.
11. 11 Balcells E, Antó JM, Gea J, et al. Characteristics of patients admitted for the first time for COPD exacerbation. Respir Med 2009; 103: 1293–1302.
12. 12 Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007; 176: 753–760.
13. 13 Ohar JA, Sadeghnejad A, Meyers DA, et al. Do symptoms predict COPD in smokers? Chest 2010; 137: 1345–1353.
14. 14 Müllerová H, Wedzicha J, Soriano JB, et al. Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys. Respir Med 2004; 98: 78–83.
15. 15 van Schayck C, Loozen JM, Wagena E, et al. Detecting patients at high risk of developing chronic obstructive pulmonary disease in a general practice: cross sectional case finding study. BMJ 2002; 324: 1370.
16. 16 Barr R, Herbstman J, Speizer FE, et al. Validation of a self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol 2002; 155: 965–971.
17. 17 Hanania NA, Mannino DM, Yawn BP, et al. Predicting risk of airflow obstruction in primary care: validation of the lung function questionnaire (LFQ). Respir Med 2010; 104: 1160–1170.
18. 18 Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD 2008; 5: 85–95.
19. 19 Freeman D, Nordyke R, Isonaka S, et al. Questions for COPD diagnostic screening in a primary care setting. Respir Med 2005; 99: 1311–1318.
20. 20 Kotz D, Nelemans P, van Schayck CP, et al. External validation of a COPD diagnostic questionnaire. Eur Respir J 2008; 31: 298–303.
21. 21 Ware JE Jr, Kosinski M. SF-36 Health Survey (version 2.0) (Technical Note, September 20). Boston, Health Assessment Lab, 1996.
22. 22 Tønnesen P, Carrozzi L, Fagerstrõm KO, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 2007; 29: 390–417.
23. 23 Buffels J, Degryse J, Decramer M, et al. Spirometry and smoking cessation advice in general practice: a randomised clinical trial. Respir Med 2006; 100: 2012–2017.
24. 24 Wilt TJ, Niewoehner D, Kane RL, et al. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res 2007; 9: 21–32.
25. 25 Parkes G, Greenhalgh T, Griffin M, et al. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008; 336: 598–600.